Gabapentin Enacarbil



Gabapentin Enacarbil





HorizantDNC

PREGNANCY CATEGORY C


Drug class

Antiepileptic


Therapeutic Actions

Mechanism of action not understood; antiepileptic activity may be related to its ability to inhibit polysynaptic responses and block posttetanic potentiation.


Indications



  • Adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children older than 12 yr with epilepsy


  • Adjunctive therapy for treatment of partial seizures in children 3–12 yr


  • Orphan drug use: Treatment of amyotrophic lateral sclerosis


  • Management of post-herpetic neuralgia in adults


  • Treatment of moderate to severe primary restless legs syndrome in adults (Horizant)


  • Unlabeled uses: Hot flashes, neuropathic pain, diabetic neuropathy, pruritus



Available Forms

Capsules—100, 300, 400 mg; tablets—100, 300, 400, 600, 800 mg; oral solution—250 mg/5 mL; ER tablets—600 mgDNC; tabletsDNC—300, 600 mg (Gralise)



Dosages

Adults



  • Epilepsy: Starting dose is 300 mg PO tid, then titrated up as needed. Maintenance: 900–1,800 mg/day PO in divided doses tid PO; maximum interval between doses should not exceed 12 hr. Up to 2,400–3,600 mg/day has been used


  • Post-herpetic neuralgia: Initial dose of 300 mg/day PO; 300 mg bid PO on day 2; 300 mg tid PO on day 3. Or, 1,800 mg/day PO with the evening meal (Gralise).


  • Moderate to severe restless legs syndrome: 600–800 mg/day PO with food, around 5 PM; maximum dose, 2,400 mg/day (Horizant).

Pediatric patients 3–12 yr

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Gabapentin Enacarbil

Full access? Get Clinical Tree

Get Clinical Tree app for offline access